Skip to main content
Kyrollis Attalla, MD, Urology, New York, NY, The Mount Sinai Hospital

KyrollisAttallaMD

Urology New York, NY

Urologic Oncologist, Icahn School of Medicine at Mount Sinai

Dr. Attalla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Attalla's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2019 - 2021
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Urology, 2015 - 2019
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Internship, Surgery, 2014 - 2015
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2014
  • Sophie Davis School of Biomedical Education
    Sophie Davis School of Biomedical EducationBachelor of Science

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2025
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • T32 Ruth L. Kirschstein Institutional National Research Service Award Memorial Sloan Kettering Cancer Center

Publications & Presentations

PubMed

Journal Articles

  • Open Partial Nephrectomy: One Night Length of Stay Is Safe and Cost Effective  
    Sirohi M, Attalla K, Nagler HM, Goluboff ET, Open Journal of Urology, 9/1/2016

Books/Book Chapters

Abstracts/Posters

  • Prevalence and landscape of actionable genomic alterations in renal cell carcinoma
    Attalla K, DiNatale RG, Reznik E, Fong C, Sanchez-Vega F, Silagy AW, Weng S, Coleman J, Lee CH, Carlo MI, Russo P, Chan TA, Motzer RJ, Schultz ND, Voss MH, Hakimi AA, ASCO GU, podium presentation, San Francisco, 2/15/2020
  • The spinal distribution of metastatic renal cell carcinoma: support for locoregional rather than arterial hematogenous mode of early bony dissemination
    Attalla K, Duzgol C, McLaughlin L, Flynn J, Ostrovnaya I, DiNatale RG, Silagy AW, Coleman J, Lee CH, Carlo MI, Voss MH, Russo P, Bilsky M, Hakimi AA, Moss N, ASCO GU, poster session, San Francisco, CA, 2/15/2020
  • Who does not receive a cytoreductive nephrectomy among IMDC intermediate-poor risk patients?
    Iosepovici S, Silagy A, Mano R, Attalla K, DiNatale R, Marcon J, Motzer RJ, Coleman JA, Russo P, Hakimi AA, Society of Urologic Oncology Annual Meeting, poster session, Washington, DC, 12/5/2019
  • Join now to see all

Authored Content

  • The Evolution of Bladder Cancer Genomics: What Have We Learned and How Can We Use It?March 2018

Press Mentions

  • Robotic, Open Radical Cystectomy Offer Similar Results
    Robotic, Open Radical Cystectomy Offer Similar ResultsJuly 10th, 2017
  • Robotic vs. Open Radical Cystectomy for Bladder Cancer
    Robotic vs. Open Radical Cystectomy for Bladder CancerJuly 10th, 2017
  • Actionable Genomic Alterations in Renal Cell Carcinoma
    Actionable Genomic Alterations in Renal Cell CarcinomaFebruary 21st, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • Arabic

Hospital Affiliations